About the study:

Dengue fever is a virus that is carried by mosquitoes, usually in subtropical and tropical climates. This could include the Caribbean, South America, and Southeast Asia. As temperatures rise across the globe, more and more areas could be affected by tropical area diseases. Symptoms can range from either mild or severe. Mild symptoms would consist of fevers, nausea/vomiting, joint pain, rashes, and headaches. Severe dengue symptoms would consist of shock, internal bleeding, and even death. Severe dengue is more common in women who are pregnant and have children. The virus only lasts about a week but if left untreated it could turn into severe symptoms. Making the need for a dengue fever vaccine more important.

There currently isn’t a vaccine for adults to prevent We are conducting a phase 2 study of a vaccine for people ages 18-50 years old to test the safety and efficiency of different doses given. It’s a one-year-long trial with 8 visits to the office.

Study-related care is available to participants at no cost and health insurance is not required nor needed. Compensation for time and travel is available up to $150 per office visit to those who qualify.


  • Between the ages of 18-50 years old
  • Can use an electronic device for the diary
  • *Please note, other conditions may apply